- Home
- Applications
- europe
- covid 19 novel vaccination
Show results for
Refine by
Covid 19 Novel Vaccination Product Applications In Europe
2 applications found
In the face of the coronavirus pandemic, it is time for the nanotechnology community to shine and build on its experience with nanoscale materials and drug delivery to provide knowledge and tools for COVID-19 [prevention, diagnostics,] vaccine and therapeutics development (Nature Nanotechnology volume 15, page 617(2020)) ...
ByPhornano Holding GmbH based in Korneuburg, AUSTRIA
At the end of 2019, a novel coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, a city in the Hubei Province of China. The severity and rapid spread of COVID-19 (caused by SARS-CoV-2), resulted in a global pandemic declared by the World Health Organization in March 2020. The virus has spread to more than 100 countries, including the United ...
ByNovavax based in Gaithersburg, MARYLAND (USA)
